APOE ε2, ε3, and ε4: How Two Amino Acid Substitutions Produce Three Different Clinical Phenotypes
LDL cholesterol rises linearly across APOE genotype, but coronary risk does not follow it. Bennet et al. (JAMA 2007; n=86,067) found a 44 mg/dL spread between the genotype extremes — and a coronary odds ratio in ε4 carriers of just 1.06 (95% CI 0.99–1.13). Three separate risk quantities are routinely quoted interchangeably in clinic, and only one of them belongs in a disclosure conversation.
